Page last updated: 2024-11-13
tetronothiodin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
tetronothiodin: from Streptomyces sp. NR0489; structure given in first source; cholecystokinin receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 54695534 |
CHEMBL ID | 3576924 |
MeSH ID | M0198846 |
Synonyms (9)
Synonym |
---|
139643-79-1 |
3h,21h-19a,22-metheno-1h-thieno(3,4-e)(1)benzoxacycloeicosin-3-acetic acid, 3a,4,5,8,9,10,15,15a,18,19,23,23a-dodecahydro-9,24-dihydroxy-4,17,18-trimethyl-alpha,21,23-trioxo- |
3a,4,5,8,9,10,15,15a,18,19,23,23a-dodecahydro-9,24-dihydroxy-4,17,18-trimethyl-alpha,21,23-trioxo-3h,21h-19a,22-metheno-1h-thieno(3,4-e)(1)benzoxacycloeicosin-3-acetic acid |
gtpl910 |
2-[(8z,10e,15e)-13,26-dihydroxy-3,4,18-trimethyl-24,28-dioxo-27-oxa-21-thiatetracyclo[23.2.1.0^{1,6}.0^{19,23}]octacosa-4,8,10,15,25-pentaen-20-yl]-2-oxoacetic acid |
tetronothiodin |
bdbm50088529 |
chembl3576924 , |
Q27088970 |
Research Excerpts
Overview
Tetronothiodin (1) is a potent and selective cholecystokinin type B (CCK-B) receptor antagonist produced by Streptomyces sp.
Excerpt | Reference | Relevance |
---|---|---|
"Tetronothiodin (1) is a potent and selective cholecystokinin type B (CCK-B) receptor antagonist produced by Streptomyces sp. " | ( Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. III. Structural elucidation. Itezono, Y; Kuwahara, T; Nakayama, N; Ohtsuka, T; Seto, H; Shimma, N; Yokose, K, 1993) | 3.17 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1346883 | Human CCK2 receptor (Cholecystokinin receptors) | 1993 | Neuroscience letters, Aug-06, Volume: 158, Issue:1 | Species specificity of pharmacological characteristics of CCK-B receptors. |
AID1225254 | Inhibition of CCK-B receptor in rat cerebral cortex | 2015 | Journal of natural products, Mar-27, Volume: 78, Issue:3 | Spirotetronate polyketides as leads in drug discovery. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.13) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (25.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (75.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |